Tasigna (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Tasigna drug offered from Novartis Pharmaceuticals Corporation. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | nilotinib |
| SUBSTANCE NAME: | NILOTINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-10-29 |
| END MARKETING DATE: | 0000-00-00 |
Tasigna HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tasigna from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2007-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0526_8862336e-5cca-43c1-88d5-f97e26e76bfd |
| PRODUCT NDC: | 0078-0526 |
| APPLICATION NUMBER: | NDA022068 |
Other NILOTINIB Pharmaceutical Manufacturers / Labelers:
